Oventus CEO and founder, Dr Chris Hart was recently interviewed by Boardroom.Media’s Velvet-Belle Templeman.
Following the release of the Oventus quarterly business review, Dr Hart discusses the roll-out of its ‘lab in lab’ model in an increasing number of sleep facilities in North America. This sleep treatment platform treats sufferers of obstructive sleep apnoea, delivering O2Vent® oral devices directly to patients at sleep facility locations.
Scroll down below and click arrow to listen:
Leave a Reply